These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
3. A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet. Ibáñez Y, Rodríguez JM, Luján M, Grattan TJ, Martin AJ, Burnett I. Curr Med Res Opin; 2006 Oct; 22(10):1893-7. PubMed ID: 17022846 [Abstract] [Full Text] [Related]
6. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy. Kelly K, O'Mahony B, Lindsay B, Jones T, Grattan TJ, Rostami-Hodjegan A, Stevens HN, Wilson CG. Pharm Res; 2003 Oct; 20(10):1668-73. PubMed ID: 14620524 [Abstract] [Full Text] [Related]
7. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L. Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [Abstract] [Full Text] [Related]
15. A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations. Smith S, Collaku A, Heaslip L, Yue Y, Starkey YY, Clarke G, Kronfeld N. Drug Dev Ind Pharm; 2012 Mar; 38(3):372-9. PubMed ID: 21961887 [Abstract] [Full Text] [Related]
16. Bioavailability and pharmacokinetic profile of a newly-developed twice-a-day sustained-release paracetamol formulation. Liu DJ, Collaku A, Youngberg SP. Int J Clin Pharmacol Ther; 2015 Feb; 53(2):172-81. PubMed ID: 25500485 [Abstract] [Full Text] [Related]
17. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. Ullah MA, Shams-Ud-Dowla, Maruf AA, Azad MA, Shohag MH, Sultana R, Latif AH, Hasnat A. Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688 [Abstract] [Full Text] [Related]
18. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Flouvat B, Leneveu A, Fitoussi S, Delhotal-Landes B, Gendron A. Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers. Cho HY, Yoon H, Park GK, Lee YB. Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013 [Abstract] [Full Text] [Related]